ASCIA Education Projects
Anaphylaxis | Food Allergy | Respiratory/Insect Allergy | Drug Allergy | Skin/Allergy | Immunodeficiency | Testing | COVID-19
The ASCIA team works with ASCIA committees and working parties to review, update and develop accessible, consistent and evidence based resources, education and training, to support ASCIA members, other health professionals, patients, carers and the community.
The following resources have been developed and/or updated in 2021.
Action Plans, Forms and Checklists
ASCIA Action Plan FAQs Updated June 2021
ASCIA Travel Plan Updated June Updated June 2021
Anaphylaxis Checklist for Adrenaline Prescribers Updated September 2021
Adrenaline Injectors for General Use Updated September 2021
Adrenaline Injectors FAQ Updated September 2021
Adrenaline Injector Storage, Expiry, Disposal Updated September 2021
Adrenaline Injector Prescription Guidelines Updated September 2021
Adrenaline for Treatment of Anaphylaxis Patient Information Updated September 2021
Anaphylaxis Patient Information - English Updated September 2021
Guidelines for Health Professionals
Anaphylaxis Guidelines - Health Professionals Updated July 2021
ASCIA Anaphylaxis e-Training Courses
Anaphylaxis e-training - Health Professionals Updated September 2021
ASCIA Anaphylaxis e-training - Pharmacists Updated September 2021
The following projects are scheduled to be completed in 2021:
- New ASCIA Anaphylaxis Refresher e-training for health professionals
- Updated ASCIA Adrenaline Injectors FAQ
The following resources have been developed and/or updated in 2021.
Information for Patients, Consumers and Carers - Food Allergy
Food Allergy FAQ Updated May 2021
Oral Immunotherapy (OIT) for Food Allergy FAQ New April 2021
ASCIA Dietary Avoidance for Food Allergy FAQ New May 2021
ASCIA Dietary Guide for Cow's Milk and Soy Allergy New May 2021
Information for Patients, Consumers and Carers - Other Adverse Reactions to Foods
Oral Allergy Syndrome FAQ New September 2021
Sulfite Sensitivity FAQ Updated July 2021
Eosinophilic Oesophagitis (EoE) FAQ New July 2021
Eosinophilic Oesophagitis (EoE) Dietary Guide - 2FED New July 2021
Eosinophilic Oesophagitis (EoE) Dietary Guide - 4FED New July 2021
Action and Management Plans
Eosinophilic Oesophagitis (EoE) Action Plan New July 2021
Eosinophilic Oesophagitis (EoE) Management Plan New July 2021
Information for Health Professionals
ASCIA Position Paper - Oral Immunotherapy for Food Allergy New April 2021
ASCIA Position Statement - Packaged Foods for Infants that Contain Most of the Common Food Allergens New April 2021
The following projects are scheduled to be completed in 2021:
- Updated ASCIA Food Allergy e-training
- New ASCIA Position Statement – Food Allergen Challenges
ASCIA Respiratory and Insect Allergy Resources
The following resources have been developed and/or updated in 2021.
ASCIA Treatment Plan – Subcutaneous Immunotherapy (SCIT) Updated May 2021
ASCIA Treatment Plan - Sublingual Immunotherapy (SLIT) New June 2021
The following projects are scheduled to be completed in 2021:
- New ASCIA Position Paper on Chronic Rhinosinusitis with Nasal Polyps
- Updated ASCIA Allergen Immunotherapy e-training for health professionals
ASCIA Drug (Medication) Allergy Resources
The following resources have been developed and/or updated in 2021.
ASCIA Action Plan for Drug (Medication) Allergy Updated June 2021
ASCIA Record for Drug (Medication) Allergy Updated June 2021
ASCIA Consensus Statement - Cephalosporin Allergy (available to Members only) New July 2021
ASCIA Skin/Allergy Resources
The following resources have been developed and/or updated in 2021.
Eczema (Atopic Dermatitis) FAQ Updated August 2021
ASCIA Action Plan for Eczema Updated August 2021
ASCIA Stepwise Management Plan for Eczema Updated August 2021
- New ASCIA Atopic Dermatitis (Eczema) information for health professionals
ASCIA Immunodeficiency Resources
The following resources have been developed and/or updated in 2021.
Information for Patients, Consumers and Carers
Common Variable Immunodeficiency (CVID) Updated October 2021
Immunoglobulin Replacement Therapy (IRT) Updated October 2021
Primary Immunodeficiency (Inborn Errors of Immunity) Updated October 2021
Severe Combined Immunodeficiency (SCID) Updated October 2021
Subcutaneous Immunoglobulin (SCIg) Therapy - General Information Updated August 2021
Information for Health Professionals
The following projects are scheduled to be completed in 2021-2022:
- New ASCIA Immunoglobulin Replacement Therapy (IRT) e-training for health professionals
- New ASCIA Hereditary Angioedema (HAE) e-training for health professionals
- Updated ASCIA PID/IEI e-training for health professionals
- New ASCIA immune system and immunodeficiency animations
- Launch and implementation of ASCIA Immunodeficiency Strategy in February 2022 www.nationalimmunodeficiencystrategy.org.au
ASCIA Testing Resources
ASCIA Position Paper - Evidence-Based Versus Non Evidence-Based Allergy Tests and Treatments New March 2021
References - Evidence-Based Versus Non Evidence-Based Allergy Tests and Treatments New March 2021
ASCIA COVID-19 Resources
The following resources have been developed and/or updated in 2021.
Information for Patients, Consumers and Carers
Allergy, Immunodeficiency, Autoimmunity and COVID-19 Vaccination - Frequently Asked Questions (FAQ) for patients, consumers and carers Updated October 2021
COVID-19 and Immunodeficiency Updated October 2021
Checklist - Actions to Reduce the Spread of COVID-19 Updated October 2021
COVID-19 Vaccination Guidelines for Clinical Immunology/Allergy Specialists Updated September 2021
Allergy, Immunodeficiency, Autoimmunity and COVID-19 Vaccination - Position Statement for health professionals Updated September 2021
Allergy and COVID-19 Vaccination - Guide for health professionals Updated September 2021
Improving Access to ASCIA information
- Vision impairment, limited reading ability or learning disabilities, by allowing text to speech (TTS).
- Non-English speaking backgrounds - information can be translated into 20 different languages by highlighting the text and selecting 'translate’.
